Welcome to our dedicated page for Aptargroup SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading ´¡±è³Ù²¹°ù³Ò°ù´Ç³Ü±è’s SEC disclosures often means wading through hundreds of pages on elastomer technology, pharma device trials, and global resin costs. Finding when executives sell shares or how the Pharma segment’s margins shift quarter-to-quarter can be a challenge.
Stock Titan solves this problem by pairing real-time EDGAR feeds with AI-powered summaries. Whether you need the AptarGroup quarterly earnings report 10-Q filing for revenue trends, an AptarGroup 8-K material events explained alert after a plant expansion, or the latest AptarGroup insider trading Form 4 transactions, our platform converts legal jargon into clear insights. Instant notifications surface every AptarGroup Form 4 insider transactions real-time so you never miss key moves by management.
What investors actually use here:
- 10-K & 10-Q � AI highlights segment performance and R&D spending, giving you an AptarGroup annual report 10-K simplified.
- 8-K � One-click summaries keep material developments in context.
- DEF 14A � The AptarGroup proxy statement executive compensation section lets you compare pay against peers.
- Form 4 � Track AptarGroup executive stock transactions Form 4 and spot buying before order book spikes.
From �understanding AptarGroup SEC documents with AI� to in-depth AptarGroup earnings report filing analysis, every document is indexed, summarized, and searchable. Save hours, monitor compliance, and make confident decisions with Stock Titan’s comprehensive coverage of AptarGroup SEC filings explained simply.
AptarGroup, Inc. (ATR) filed a Form 144 reporting a proposed sale of 1,167 common shares. The sale is to be handled by Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $161,006.44 and an approximate sale date of 09/05/2025. The shares were acquired on 05/02/2025 through restricted stock vesting under a registered plan and were issued by the issuer as payment for services rendered on 05/02/2025. The filer reports no securities sold in the past three months. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.